Published in Acta Biochim Biophys Sin (Shanghai) on January 03, 2014
MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling. Oncotarget (2014) 1.04
MicroRNA-410 suppresses migration and invasion by targeting MDM2 in gastric cancer. PLoS One (2014) 0.96
Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors. Sci Rep (2016) 0.82
Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis. Mol Diagn Ther (2015) 0.80
Identifying Driver Genomic Alterations in Cancers by Searching Minimum-Weight, Mutually Exclusive Sets. PLoS Comput Biol (2015) 0.78
NEDD4: a promising target for cancer therapy. Curr Cancer Drug Targets (2014) 0.78
Essential Roles of E3 Ubiquitin Ligases in p53 Regulation. Int J Mol Sci (2017) 0.77
Chemical Variations on the p53 Reactivation Theme. Pharmaceuticals (Basel) (2016) 0.77
Hyper-progressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate. Clin Cancer Res (2017) 0.76
Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer. Oncoimmunology (2016) 0.75
Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB. Genes Cancer (2016) 0.75
Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death. Oncotarget (2015) 0.75
Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis. Hepatoma Res (2016) 0.75
miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells. Onco Targets Ther (2017) 0.75
Nutlin-3a Nanodisks Induce p53 Stabilization and Apoptosis in a Subset of Cultured Glioblastoma Cells. J Nanomed Nanotechnol (2017) 0.75
The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence. Cancer Lett (2017) 0.75
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell (1992) 16.53
Cancer. p53, guardian of the genome. Nature (1992) 16.36
The economics of ribosome biosynthesis in yeast. Trends Biochem Sci (1999) 15.22
The p53-mdm-2 autoregulatory feedback loop. Genes Dev (1993) 11.19
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett (1997) 11.19
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature (1995) 10.18
Recognition of the polyubiquitin proteolytic signal. EMBO J (2000) 10.12
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell (2004) 8.48
Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet (2004) 8.30
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell (2004) 8.18
mdm2 expression is induced by wild type p53 activity. EMBO J (1993) 8.01
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (1993) 7.90
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell (2004) 7.22
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev (1999) 6.87
A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev (1999) 6.34
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol (2001) 5.82
Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol (1999) 5.78
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nat Med (2004) 5.48
Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol (1993) 5.31
Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science (2003) 5.23
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol (2008) 5.19
p53 mutations in cancer. Nat Cell Biol (2013) 5.18
Divorcing ARF and p53: an unsettled case. Nat Rev Cancer (2006) 5.17
Binding and modulation of p53 by p300/CBP coactivators. Nature (1997) 5.12
Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J (1998) 4.98
The MDM2 gene amplification database. Nucleic Acids Res (1998) 4.64
Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J (1991) 4.33
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet (2001) 4.23
Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell (2005) 4.16
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell (2012) 4.09
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proc Natl Acad Sci U S A (2008) 4.07
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev (2001) 4.06
Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol (2008) 3.90
Signaling to p53: ribosomal proteins find their way. Cancer Cell (2009) 3.84
Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci U S A (2000) 3.74
Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (1995) 3.39
p53 dynamics control cell fate. Science (2012) 3.30
p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell (1998) 3.27
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer Res (2006) 3.26
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A (1997) 3.19
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev (2008) 3.17
MDM2 interacts with MDMX through their RING finger domains. FEBS Lett (1999) 2.98
Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol Cell (1999) 2.93
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc Natl Acad Sci U S A (2003) 2.73
Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide. J Am Chem Soc (2007) 2.71
Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68
MdmX protects p53 from Mdm2-mediated degradation. Mol Cell Biol (2000) 2.50
Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet (1987) 2.48
Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol Cell (2008) 2.46
Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci U S A (2007) 2.36
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ (2008) 2.36
The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell (2007) 2.32
The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev (2010) 2.27
The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity. EMBO J (2006) 2.21
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. Proc Natl Acad Sci U S A (2005) 2.19
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell (2005) 2.17
BCR/ABL activates mdm2 mRNA translation via the La antigen. Cancer Cell (2003) 2.08
Identification of a cryptic nucleolar-localization signal in MDM2. Nat Cell Biol (2000) 2.02
The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci U S A (1993) 2.01
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci U S A (1998) 2.00
miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. EMBO J (2011) 1.98
Stressful life events and risk of breast cancer in 10,808 women: a cohort study. Am J Epidemiol (2003) 1.85
The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst (2013) 1.76
Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol Cell Biol (2006) 1.76
MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol (2006) 1.75
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat Med (1996) 1.68
The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo. Proc Natl Acad Sci U S A (2011) 1.66
An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2. Oncogene (2001) 1.66
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1. Nature (2011) 1.64
A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network. Cancer Cell (2006) 1.64
MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J Biol Chem (2009) 1.63
Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53. J Mol Biol (2006) 1.61
Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell (2009) 1.60
Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene (2012) 1.58
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity. EMBO J (2009) 1.56
Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4. Cancer Res (2006) 1.47
Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J (2002) 1.45
ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage. Mol Cell (2012) 1.40
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians. Cancer Cell (2011) 1.40
Depression and functional status as predictors of death among cancer patients. Cancer (2002) 1.38
p53 mediates the negative regulation of MDM2 by orphan receptor TR3. EMBO J (2006) 1.30
The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell (2012) 1.30
The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress. Mol Cell Biol (2000) 1.30
miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res (2010) 1.29
MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination. J Biol Chem (2011) 1.27
The RING domain of Mdm2 can inhibit cell proliferation. Cancer Res (2002) 1.26
Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res (2001) 1.25
PTEN regulates Mdm2 expression through the P1 promoter. J Biol Chem (2004) 1.25
MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett (2013) 1.24
MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination. J Biol Chem (2002) 1.24
The RP-Mdm2-p53 pathway and tumorigenesis. Oncotarget (2011) 1.23
Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS One (2013) 1.22
Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization. Proc Natl Acad Sci U S A (2012) 1.21
Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export. Oncogene (2003) 1.21
The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger. Trends Biochem Sci (1994) 1.20
CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability. J Biol Chem (2009) 1.19
Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis. Nat Commun (2013) 1.19
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci U S A (2012) 1.18
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell (2004) 8.18
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res (2007) 3.55
MDM2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets (2005) 3.04
Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci U S A (2006) 2.74
Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci U S A (2007) 2.36
A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci U S A (2005) 2.32
Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer. J Natl Cancer Inst (2002) 1.95
A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect. Cancer Res (2005) 1.90
The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol (2009) 1.90
Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci U S A (2011) 1.87
Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J Clin Invest (2011) 1.81
Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proc Natl Acad Sci U S A (2009) 1.79
The tumor suppressor p53: cancer and aging. Cell Cycle (2008) 1.66
Allosteric activation of functionally asymmetric RAF kinase dimers. Cell (2013) 1.60
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. J Clin Invest (2016) 1.48
Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF. Proc Natl Acad Sci U S A (2011) 1.44
Tumor suppressor p53 meets microRNAs. J Mol Cell Biol (2011) 1.39
Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am J Hum Genet (2009) 1.29
Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci U S A (2004) 1.26
Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc Natl Acad Sci U S A (2005) 1.18
Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation. Cancer Res (2012) 1.17
Mutational spectrum and genotoxicity of the major lipid peroxidation product, trans-4-hydroxy-2-nonenal, induced DNA adducts in nucleotide excision repair-proficient and -deficient human cells. Biochemistry (2003) 1.16
Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts. Cancer Res (2002) 1.15
4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis (2002) 1.12
LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway. Oncotarget (2014) 1.08
Regulation of female reproduction by p53 and its family members. FASEB J (2011) 1.08
Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proc Natl Acad Sci U S A (2012) 1.08
Thickness sensing of hMSCs on collagen gel directs stem cell fate. Biochem Biophys Res Commun (2010) 1.05
Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One (2011) 1.04
A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer. Carcinogenesis (2009) 1.03
Formation of trans-4-hydroxy-2-nonenal- and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. Mutat Res (2003) 1.01
Micropatterned matrix directs differentiation of human mesenchymal stem cells towards myocardial lineage. Exp Cell Res (2010) 1.00
N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation. Biochemistry (2002) 1.00
Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer. BMC Cancer (2014) 0.99
Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis. FASEB J (2009) 0.99
Combined effects of nano-hydroxyapatite and Galla chinensis on remineralisation of initial enamel lesion in vitro. J Dent (2010) 0.99
Acrolein induced DNA damage, mutagenicity and effect on DNA repair. Mol Nutr Food Res (2011) 0.97
Effects of mechanical vibration on proliferation and osteogenic differentiation of human periodontal ligament stem cells. Arch Oral Biol (2012) 0.96
Multiscale topological guidance for cell alignment via direct laser writing on biodegradable polymer. Tissue Eng Part C Methods (2010) 0.94
Malondialdehyde, a major endogenous lipid peroxidation product, sensitizes human cells to UV- and BPDE-induced killing and mutagenesis through inhibition of nucleotide excision repair. Mutat Res (2006) 0.93
Osteogenic differentiation of bone marrow-derived mesenchymal stromal cells on bone-derived scaffolds: effect of microvibration and role of ERK1/2 activation. Eur Cell Mater (2011) 0.93
Reconstructing signal transduction pathways: challenges and opportunities. Ann N Y Acad Sci (2007) 0.92
Effectiveness of problem-based learning in Chinese dental education: a meta-analysis. J Dent Educ (2013) 0.92
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma. Oncotarget (2014) 0.91
The regulation of human reproduction by p53 and its pathway. Cell Cycle (2009) 0.90
Transcription-coupled DNA repair is genomic context-dependent. J Biol Chem (2002) 0.90
Validating the mitotic kinesin Eg5 as a therapeutic target in pancreatic cancer cells and tumor xenografts using a specific inhibitor. Biochem Pharmacol (2008) 0.89
Structural mechanism of ring-opening reaction of glucose by human serum albumin. J Biol Chem (2013) 0.88
Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells. Carcinogenesis (2003) 0.87
Size influences the cytotoxicity of poly (lactic-co-glycolic acid) (PLGA) and titanium dioxide (TiO(2)) nanoparticles. Arch Toxicol (2012) 0.87
25-Hydroxyvitamin D3 attenuates experimental periodontitis through downregulation of TLR4 and JAK1/STAT3 signaling in diabetic mice. J Steroid Biochem Mol Biol (2013) 0.86
Effect of chronic kidney disease on the healing of titanium implants. Bone (2013) 0.85
Bio-inspired micropatterned platform to steer stem cell differentiation. Small (2011) 0.85
Identification and characterization of a hepcidin from half-smooth tongue sole Cynoglossus semilaevis. Fish Shellfish Immunol (2012) 0.85
Cyclic tensile loading regulates human mesenchymal stem cell differentiation into neuron-like phenotype. J Tissue Eng Regen Med (2012) 0.85
Prognostic Role of Tumor-Infiltrating Lymphocytes in Lung Cancer: a Meta-Analysis. Cell Physiol Biochem (2015) 0.85
Structural basis for therapeutic intervention of uPA/uPAR system. Curr Drug Targets (2011) 0.81
Size of TiO(2) nanoparticles influences their phototoxicity: an in vitro investigation. Arch Toxicol (2012) 0.81
TAp63γ enhances nucleotide excision repair through transcriptional regulation of DNA repair genes. DNA Repair (Amst) (2011) 0.81
Assessment of residual alveolar bone volume in hemodialysis patients using CBCT. Clin Oral Investig (2015) 0.80
pH-Triggered charge-reversal polypeptide nanoparticles for cisplatin delivery: preparation and in vitro evaluation. Biomacromolecules (2013) 0.80
Posterior extrapleural intervertebral space release combined with wedge osteotomy for the treatment of severe rigid scoliosis. Spine (Phila Pa 1976) (2012) 0.80
Near infrared light-actuated gold nanorods with cisplatin-polypeptide wrapping for targeted therapy of triple negative breast cancer. Nanoscale (2015) 0.80
Mutation in promoter region of a serine protease inhibitor confers Perkinsus marinus resistance in the eastern oyster (Crassostrea virginica). Fish Shellfish Immunol (2012) 0.79
A generic micropatterning platform to direct human mesenchymal stem cells from different origins towards myogenic differentiation. Macromol Biosci (2013) 0.79
Fluoridated hydroxyapatite coatings on titanium obtained by electrochemical deposition. Acta Biomater (2009) 0.79
Hypoxia induces osteogenic/angiogenic responses of bone marrow-derived mesenchymal stromal cells seeded on bone-derived scaffolds via ERK1/2 and p38 pathways. Biotechnol Bioeng (2013) 0.78
Effect of FDC-SP on the phenotype expression of cultured periodontal ligament cells. Arch Med Sci (2011) 0.78
[Reconstituting turkey herpesvirus with bacterial artificial chromosome clones]. Wei Sheng Wu Xue Bao (2008) 0.78
Effects of genomic context and chromatin structure on transcription-coupled and global genomic repair in mammalian cells. Nucleic Acids Res (2003) 0.78
Axl-targeted cancer imaging with humanized antibody h173. Mol Imaging Biol (2014) 0.78
Ectropis obliqua picorna-like virus IRES-driven internal initiation of translation in cell systems derived from different origins. J Gen Virol (2007) 0.78
A novel porous bioceramics scaffold by accumulating hydroxyapatite spherules for large bone tissue engineering in vivo. I. Preparation and characterization of scaffold. J Biomed Mater Res A (2010) 0.77
Induction of myogenic differentiation of human mesenchymal stem cells cultured on Notch agonist (Jagged-1) modified biodegradable scaffold surface. ACS Appl Mater Interfaces (2014) 0.77
Isolation and identification of a new tetravirus from Dendrolimus punctatus larvae collected from Yunnan Province, China. J Gen Virol (2005) 0.77
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. J Clin Invest (2016) 0.77
Investigating the spatial distribution of integrin β₁ in patterned human mesenchymal stem cells using super-resolution imaging. ACS Appl Mater Interfaces (2014) 0.77
Molecular cloning, tissue distribution, and ontogeny of gonadotropin-releasing hormone III gene (GnRH-III) in half-smooth tongue sole (Cynoglossus semilaevis). Comp Biochem Physiol B Biochem Mol Biol (2012) 0.77
Sequencing and characterization of the transcriptome of half-smooth tongue sole (Cynoglossus semilaevis). BMC Genomics (2014) 0.77
Suture compression induced bone resorption with intensified MMP-1 and 13 expressions. Bone (2012) 0.76
[Lignans from stems of Sambucus williamsii]. Zhongguo Zhong Yao Za Zhi (2009) 0.76
Small-molecule inhibition of Aurora kinases triggers spindle checkpoint-independent apoptosis in cancer cells. Biochem Pharmacol (2007) 0.76
Molecular characterization and expression pattern of two zona pellucida genes in half-smooth tongue sole (Cynoglossus semilaevis). Comp Biochem Physiol B Biochem Mol Biol (2010) 0.76
A mouse model of interstitial pneumonitis induced by murine cytomegalovirus infection after allogeneic skin transplantation. Biomed Res Int (2013) 0.75
Early gene expression in salivary gland after isoproterenol treatment. J Cell Biochem (2015) 0.75
Polypeptide/doxorubicin hydrochloride polymersomes prepared through organic solvent-free technique as a smart drug delivery platform. Macromol Biosci (2013) 0.75
Surgical treatment of severe congenital scoliosis with unilateral unsegmented bar by concave costovertebral joint release and both-ends wedge osteotomy via posterior approach. Eur Spine J (2011) 0.75
Anterior column opening structural bone grafting with posterior column compression technique for the treatment of obsolete vertebral compression fractures with severe spinal kyphosis. J Back Musculoskelet Rehabil (2019) 0.75
Dental laboratory technology education in China: current situation and challenges. J Dent Educ (2013) 0.75
A microsatellite genetic linkage map of half smooth tongue sole (Cynoglossus semilaevis). Mar Genomics (2012) 0.75
Tunable pH-sensitive poly(β-amino ester)s synthesized from primary amines and diacrylates for intracellular drug delivery. Macromol Biosci (2012) 0.75
[Analysis and suggestion management system of wild medicinal resources]. Zhongguo Zhong Yao Za Zhi (2009) 0.75
Enhanced Electrocatalytic Activity of Murdochite-type Ni6MnO8 for Water Oxidation via Surface Reconstruction. ACS Appl Mater Interfaces (2020) 0.75
Combretastatin A4 Nanoparticles Combined with Hypoxia-sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment. Nano Lett (2019) 0.75
Lower Bmi-1 Expression May Predict Longer Survival of Colon Cancer Patients. Cell Physiol Biochem (2016) 0.75
Crystallization behavior of asymmetric PLLA/PDLA blends. J Phys Chem B (2011) 0.75
[The effect of bleaching on fracture resistance in human dentin]. Hua Xi Kou Qiang Yi Xue Za Zhi (2012) 0.75
[Nano-scratch research of amelogenesis imperfecta teeth]. Hua Xi Kou Qiang Yi Xue Za Zhi (2012) 0.75